Oragenics Statistics
Share Statistics
Oragenics has 21.48M
shares outstanding. The number of shares has increased by 284.81%
in one year.
| Shares Outstanding | 21.48M |
| Shares Change (YoY) | 284.81% |
| Shares Change (QoQ) | 70.84% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 327 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 515.55K, so 2.4% of the outstanding
shares have been sold short.
| Short Interest | 515.55K |
| Short % of Shares Out | 2.4% |
| Short % of Float | 2.46% |
| Short Ratio (days to cover) | 1.04 |
Valuation Ratios
The PE ratio is -0.23 and the forward
PE ratio is -0.54.
Oragenics's PEG ratio is
0.
| PE Ratio | -0.23 |
| Forward PE | -0.54 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | -11.54 |
| P/FCF Ratio | -0.28 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Oragenics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.87,
with a Debt / Equity ratio of -1.55.
| Current Ratio | 0.87 |
| Quick Ratio | 0.87 |
| Debt / Equity | -1.55 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.04 |
| Interest Coverage | 353.99 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-3,522,639.33 |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -81.9% in the
last 52 weeks. The beta is 0.87, so Oragenics's
price volatility has been higher than the market average.
| Beta | 0.87 |
| 52-Week Price Change | -81.9% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.46 |
| Relative Strength Index (RSI) | 46.1 |
| Average Volume (20 Days) | 4,951,859 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.56M |
| Net Income | -10.57M |
| EBITDA | -10.56M |
| EBIT | -10.6M |
| Earnings Per Share (EPS) | -1.6 |
Full Income StatementBalance Sheet
The company has 864.84K in cash and 328.53K in
debt, giving a net cash position of 536.31K.
| Cash & Cash Equivalents | 864.84K |
| Total Debt | 328.53K |
| Net Cash | 536.31K |
| Retained Earnings | -216.79M |
| Total Assets | 1.47M |
| Working Capital | -211.88K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.6M
and capital expenditures 0, giving a free cash flow of -8.6M.
| Operating Cash Flow | -8.6M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.6M |
| FCF Per Share | -1.3 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
